Penumbra Total Assets 2014-2025 | PEN
Penumbra total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Penumbra total assets for the quarter ending June 30, 2025 were $1.675B, a 9.14% increase year-over-year.
- Penumbra total assets for 2024 were $1.533B, a 1.49% decline from 2023.
- Penumbra total assets for 2023 were $1.556B, a 13.53% increase from 2022.
- Penumbra total assets for 2022 were $1.371B, a 10.18% increase from 2021.
| Penumbra Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,533 |
| 2023 | $1,556 |
| 2022 | $1,371 |
| 2021 | $1,244 |
| 2020 | $823 |
| 2019 | $666 |
| 2018 | $515 |
| 2017 | $477 |
| 2016 | $308 |
| 2015 | $264 |
| 2014 | $121 |
| 2013 | $71 |
| Penumbra Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,675 |
| 2025-03-31 | $1,593 |
| 2024-12-31 | $1,533 |
| 2024-09-30 | $1,479 |
| 2024-06-30 | $1,535 |
| 2024-03-31 | $1,580 |
| 2023-12-31 | $1,556 |
| 2023-09-30 | $1,468 |
| 2023-06-30 | $1,433 |
| 2023-03-31 | $1,395 |
| 2022-12-31 | $1,371 |
| 2022-09-30 | $1,322 |
| 2022-06-30 | $1,328 |
| 2022-03-31 | $1,302 |
| 2021-12-31 | $1,244 |
| 2021-09-30 | $973 |
| 2021-06-30 | $910 |
| 2021-03-31 | $841 |
| 2020-12-31 | $823 |
| 2020-09-30 | $810 |
| 2020-06-30 | $780 |
| 2020-03-31 | $664 |
| 2019-12-31 | $666 |
| 2019-09-30 | $614 |
| 2019-06-30 | $585 |
| 2019-03-31 | $569 |
| 2018-12-31 | $515 |
| 2018-09-30 | $501 |
| 2018-06-30 | $499 |
| 2018-03-31 | $490 |
| 2017-12-31 | $477 |
| 2017-09-30 | $459 |
| 2017-06-30 | $417 |
| 2017-03-31 | $418 |
| 2016-12-31 | $308 |
| 2016-09-30 | $297 |
| 2016-06-30 | $284 |
| 2016-03-31 | $275 |
| 2015-12-31 | $264 |
| 2015-09-30 | $259 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2013-12-31 | $71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.410B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.320B | 22.30 |
| Intuitive Surgical (ISRG) | United States | $168.896B | 70.01 |
| IDEXX Laboratories (IDXX) | United States | $51.272B | 53.36 |
| Edwards Lifesciences (EW) | United States | $47.496B | 31.48 |
| Alcon (ALC) | Switzerland | $40.130B | 26.94 |
| IQVIA Holdings (IQV) | United States | $32.096B | 18.14 |
| DexCom (DXCM) | United States | $29.953B | 44.93 |
| Mettler-Toledo (MTD) | United States | $26.475B | 31.42 |
| STERIS (STE) | Ireland | $24.522B | 26.10 |
| Waters (WAT) | United States | $17.538B | 24.09 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.006B | 0.00 |
| Hologic (HOLX) | United States | $14.842B | 16.08 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Sysmex ADR (SSMXY) | Japan | $8.057B | 25.60 |
| Masimo (MASI) | United States | $7.741B | 26.05 |
| Teleflex (TFX) | United States | $5.723B | 9.24 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| TransMedics (TMDX) | United States | $4.002B | 60.82 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.89 |
| LivaNova (LIVN) | United Kingdom | $3.084B | 17.65 |
| Alphatec Holdings (ATEC) | United States | $2.394B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $2.251B | 31.10 |
| Artivion (AORT) | United States | $2.064B | 104.14 |
| Nihon Kohden (NHNKY) | Japan | $1.907B | 22.76 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 17.66 |
| Integra LifeSciences Holdings (IART) | United States | $1.159B | 6.64 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| IRadimed (IRMD) | United States | $0.939B | 45.59 |
| Tandem Diabetes Care (TNDM) | United States | $0.828B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.825B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.716B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.469B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.452B | 3.63 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.383B | 91.17 |
| Mesa Laboratories (MLAB) | United States | $0.378B | 9.62 |
| RxSight (RXST) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.294B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.293B | 20.23 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.286B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.185B | 0.00 |
| Accuray (ARAY) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.113B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.31 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |